Next |
home / stock / alpmy / alpmy message board
Subject | By | Source | When |
---|---|---|---|
$ALPMY Lets go go go go... Up up and away we go. | SPORT19 | investorshub | 07/02/2023 2:22:09 PM |
bears and bulls | jtrenee89 | investorshub | 07/01/2023 10:34:52 PM |
Thoughts on where this is headed? | rdfdr1 | investorshub | 06/29/2023 4:31:26 PM |
bears and bulls | Sam0 | investorshub | 06/27/2023 3:56:52 AM |
$ALPMY and the shorts continue | johnsyn | investorshub | 06/22/2023 2:00:01 PM |
$ALPMY Looks pretty positive | rdfdr1 | investorshub | 06/21/2023 4:39:49 AM |
$ALPMY Price trading | johnsyn | investorshub | 06/16/2023 5:57:43 PM |
what does this mean? | SPORT19 | investorshub | 06/16/2023 9:39:58 AM |
$ALPMY When is this gonna take off? | mlkrborn | investorshub | 06/16/2023 1:05:33 AM |
$ALPMY MomentumIts trading last trade up | surf1944 | investorshub | 06/15/2023 3:31:19 PM |
$ALPMY The trading | kyrie717 | investorshub | 06/09/2023 12:33:03 PM |
$ALPMY oh yeah news for the day | johnsyn | investorshub | 06/07/2023 2:36:29 AM |
whytestocks: $ALPMY News Article - Astellas to Present Findings from Phase 3 Long-Term Safety Study | whytestocks | investorshangout | 10/12/2022 12:10:55 PM |
whytestocks: $ALPMY News Article - Here's What Recent News From the FDA Means for AstraZeneca | whytestocks | investorshangout | 08/20/2021 12:50:48 PM |
whytestocks: $ALPMY News Article - U.S. FDA Grants Regular Approval and Expands Indication for PADCE | whytestocks | investorshangout | 07/09/2021 6:35:50 PM |
SPORT19, thanks for the Astellas link. I | scoobey-do | investorshub | 01/02/2021 5:16:06 PM |
One week ago ProtoKinetix $CEO Clarence Smith posted | SPORT19 | investorshub | 01/02/2021 4:36:52 PM |
Astellas Innovation Management ($AIM) sounds like a partnership | SPORT19 | investorshub | 01/02/2021 4:35:34 PM |
Heres another MUST WATCH Astellas Institute of Regenerative | SPORT19 | investorshub | 01/02/2021 4:34:08 PM |
Astellas has undergone a MASSIVE expansion of its | SPORT19 | investorshub | 01/02/2021 4:33:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Astellas Pharma Inc. ADR Company Name:
ALPMY Stock Symbol:
OTCMKTS Market:
Astellas and Graduate School of Medicine / Faculty of Medicine, Osaka University Enter into Research Collaboration to Develop Pluripotent Stem Cell-Derived Cartilage Organoid Cell Therapy PR Newswire - Collaborative Research on Innovative Cartilage Organoid Cell Therapy for In...
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE PR Newswire If approved, the investigational therapy would offer a new treatment option for patients with advanced gastric and gastroesophageal junction canc...
Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies PR Newswire - Focuses on digitizing cell manufacturing processes through robotics technology TOKYO ,...